MediKarma Validates "Agentic AI" in Clinical Intervention Study: Demonstrates 50% A1C Reduction; Proves Friction-Free Alternative to ChatGPT
PR Newswire —
A breakthrough intervention with Dallas Endocrinology proves that autonomous AI agents can bridge the "between-visit" care gap – delivering outcomes that secured a 20,000-unit deployment with Family Health Choice (FHC). SAN FRANCISCO, Feb. 17, 2026 /PRNewswire/ -- MediKarma, an AI-driven...